{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:02:43Z","timestamp":1767020563935,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72204039"],"award-info":[{"award-number":["72204039"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Natural Science Foundation of Sichuan Province","award":["23NSFSC4722"],"award-info":[{"award-number":["23NSFSC4722"]}]},{"name":"Basic Research Projects of Central Universities","award":["ZYGX2021J033"],"award-info":[{"award-number":["ZYGX2021J033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15248-9","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:58:16Z","timestamp":1767020296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of the CHI-CAT score: a novel tool for assessing cancer-associated venous thromboembolism risk in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoli","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiurong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"24","key":"15248_CR1","doi-asserted-by":"publisher","first-page":"e914","DOI":"10.1161\/CIR.0000000000000769","volume":"141","author":"PK Henke","year":"2020","unstructured":"Henke PK, Kahn SR, Pannucci CJ, et al. Call to action to prevent venous thromboembolism in hospitalized patients: A policy statement from the American heart Association. Circulation. 2020;141(24):e914-31.","journal-title":"Circulation."},{"issue":"7","key":"15248_CR2","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/jth.14139","volume":"16","author":"A Parker","year":"2018","unstructured":"Parker A, Peterson E, Lee A, et al. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer. J Thromb Haemost. 2018;16(7):1321\u20136.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"15248_CR3","doi-asserted-by":"publisher","first-page":"e250723","DOI":"10.1371\/journal.pone.0250723","volume":"16","author":"JS Yuk","year":"2021","unstructured":"Yuk JS, Lee B, Kim K, et al. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study. PLoS ONE. 2021;16(4):e250723.","journal-title":"PLoS ONE"},{"issue":"3","key":"15248_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632\u20134.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"15248_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1160\/TH16-08-0615","volume":"117","author":"C Ay","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219\u201330.","journal-title":"Thromb Haemost"},{"issue":"6","key":"15248_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ajh.24700","volume":"92","author":"R Patell","year":"2017","unstructured":"Patell R, Rybicki L, McCrae KR, et al. Predicting risk of venous thromboembolism in hospitalized cancer patients: utility of a risk assessment tool. Am J Hematol. 2017;92(6):501\u20137.","journal-title":"Am J Hematol"},{"issue":"6","key":"15248_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1055\/s-0040-1718926","volume":"47","author":"J Costa","year":"2021","unstructured":"Costa J, Ara\u00fajo A. Cancer-Related venous thromboembolism: from pathogenesis to risk Assessment. Semin Thromb Hemost. 2021;47(6):669\u201376.","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"15248_CR8","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902\u20137.","journal-title":"Blood"},{"key":"15248_CR9","doi-asserted-by":"crossref","unstructured":"Angelini DE, Greene MT, Wietzke JN et al. A novel risk assessment model to predict venous thromboembolism (VTE) in cancer inpatients: the Canclot score. Blood. 2016;128(22):1181.","DOI":"10.1182\/blood.V128.22.1181.1181"},{"issue":"8","key":"15248_CR10","first-page":"3755","volume":"28","author":"CM Rojas-Hernandez","year":"2020","unstructured":"Rojas-Hernandez CM, Tang VK, Sanchez-Petitto G, et al. Development of a clinical prediction tool for cancer-associated venous thromboembolism (CAT): the MD Anderson cancer center CAT model. Support Care Cancer. 2020;28(8):3755\u201361.","journal-title":"Support Care Cancer"},{"issue":"7","key":"15248_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.6004\/jnccn.2018.7273","volume":"17","author":"A Li","year":"2019","unstructured":"Li A, Wu Q, Luo S, et al. Derivation and validation of a risk assessment model for Immunomodulatory Drug-Associated thrombosis among patients with multiple Myeloma. J Natl Compr Canc Netw. 2019;17(7):840\u20137.","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"15248_CR12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ajh.25603","volume":"94","author":"KM Sanfilippo","year":"2019","unstructured":"Sanfilippo KM, Luo S, Wang TF, et al. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol. 2019;94(11):1176\u201384.","journal-title":"Am J Hematol"},{"issue":"3","key":"15248_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","volume":"7","author":"M Verso","year":"2012","unstructured":"Verso M, Agnelli G, Barni S, et al. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the protecht score. Intern Emerg Med. 2012;7(3):291\u20132.","journal-title":"Intern Emerg Med"},{"issue":"5","key":"15248_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","volume":"22","author":"CA Cella","year":"2017","unstructured":"Cella CA, Di Minno G, Carlomagno C, et al. Preventing venous thromboembolism in ambulatory cancer patients: the ONKOTEV Study. Oncologist. 2017;22(5):601\u20138.","journal-title":"Oncologist"},{"issue":"8","key":"15248_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41416-018-0027-8","volume":"118","author":"MA Munoz","year":"2018","unstructured":"Munoz MA, Ortega I, Font C, et al. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer. 2018;118(8):1056\u201361.","journal-title":"Br J Cancer"},{"issue":"21","key":"15248_CR16","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1002\/cam4.4280","volume":"10","author":"M Bastos-Oreiro","year":"2021","unstructured":"Bastos-Oreiro M, Ortiz J, Pradillo V, et al. Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma. Cancer Med. 2021;10(21):7585\u201392.","journal-title":"Cancer Med"},{"issue":"4","key":"15248_CR17","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.21037\/tlcr-21-109","volume":"10","author":"Y Li","year":"2021","unstructured":"Li Y, Shen L, Ding J, et al. Derivation and validation of a nomogram model for pulmonary thromboembolism in patients undergoing lung cancer surgery. Transl Lung Cancer Res. 2021;10(4):1829\u201340.","journal-title":"Transl Lung Cancer Res"},{"issue":"10","key":"15248_CR18","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/jth.14564","volume":"17","author":"TF Wang","year":"2019","unstructured":"Wang TF, Zwicker JI, Ay C, et al. The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2019;17(10):1772\u20138.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"15248_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12884-022-04700-4","volume":"22","author":"M Zhang","year":"2022","unstructured":"Zhang M, Liu M, Wang D, et al. Development of a risk assessment scale for perinatal venous thromboembolism in Chinese women using a Delphi-AHP approach. BMC Pregnancy Childbirth. 2022;22(1):426.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"15248_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/icvts\/ivaa137","volume":"31","author":"Y Hu","year":"2020","unstructured":"Hu Y, Li X, Zhou H, et al. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study. Interact Cardiovasc Thorac Surg. 2020;31(4):454\u201360.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"2","key":"15248_CR21","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.opresp.2022.100170","volume":"4","author":"LAF Bermejo","year":"2022","unstructured":"Bermejo LAF, Esteban JJJ, D\u00edez JM, et al. Evaluation of the Khorana predictive thrombotic risk and thromboprophylaxis score in cancer patients in a third level hospital. Open Respir Arch. 2022;4(2):100170.","journal-title":"Open Respir Arch"},{"issue":"1","key":"15248_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12885-024-11877-8","volume":"24","author":"X Qin","year":"2024","unstructured":"Qin X, Gao X, Yang Y, et al. Developing a risk assessment tool for cancer-related venous thrombosis in china: a modified Delphi-analytic hierarchy process study. BMC Cancer. 2024;24(1):120.","journal-title":"BMC Cancer"},{"issue":"10","key":"15248_CR23","first-page":"1181","volume":"19","author":"MB Streiff","year":"2021","unstructured":"Streiff MB, Holmstrom B, Angelini D, et al. Cancer-Associated venous thromboembolic Disease, version 2.2021, NCCN clinical practice guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(10):1181\u2013201.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"15248_CR24","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/ajh.24466","volume":"91","author":"D Antic","year":"2016","unstructured":"Antic D, Milic N, Nikolovski S, et al. Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients. Am J Hematol. 2016;91(10):1014\u20139.","journal-title":"Am J Hematol"},{"issue":"9","key":"15248_CR25","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s11136-014-0704-x","volume":"23","author":"M Mean","year":"2014","unstructured":"Mean M, Limacher A, Kahn SR, et al. The VEINES-QOL\/Sym questionnaire is a reliable and valid disease-specific quality of life measure for deep vein thrombosis in elderly patients. Qual Life Res. 2014;23(9):2463\u201371.","journal-title":"Qual Life Res"},{"issue":"7","key":"15248_CR26","doi-asserted-by":"publisher","first-page":"e1083","DOI":"10.1634\/theoncologist.2019-0482","volume":"25","author":"AC Spyropoulos","year":"2020","unstructured":"Spyropoulos AC, Eldredge JB, Anand LN, et al. External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: the COMPASS-CAT venous thromboembolism risk assessment Model. Oncologist. 2020;25(7):e1083\u201390.","journal-title":"Oncologist"},{"issue":"6","key":"15248_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217748","volume":"14","author":"D Douillet","year":"2019","unstructured":"Douillet D, Nemeth B, Penaloza A, et al. Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization. PLoS ONE. 2019;14(6):e217748.","journal-title":"PLoS ONE"},{"issue":"6","key":"15248_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1055\/s-0040-1718926","volume":"47","author":"J Costa","year":"2021","unstructured":"Costa J, Araujo A. Cancer-Related venous thromboembolism: from pathogenesis to risk Assessment. Semin Thromb Hemost. 2021;47(6):669\u201376.","journal-title":"Semin Thromb Hemost."},{"issue":"1","key":"15248_CR29","doi-asserted-by":"publisher","first-page":"18200","DOI":"10.1038\/s41598-021-97659-9","volume":"11","author":"F Nichetti","year":"2021","unstructured":"Nichetti F, Ligorio F, Montelatici G, et al. Risk assessment of thromboembolic events in hospitalized cancer patients. Sci Rep. 2021;11(1):18200.","journal-title":"Sci Rep"},{"issue":"3","key":"15248_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/jth.13594","volume":"15","author":"S Noble","year":"2017","unstructured":"Noble S, Alikhan R, Robbins A, et al. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment. J Thromb Haemost. 2017;15(3):590\u20131.","journal-title":"J Thromb Haemost"},{"key":"15248_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.thromres.2016.12.013","volume":"150","author":"N van Es","year":"2017","unstructured":"van Es N, Franke VF, Middeldorp S, et al. The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer. Thromb Res. 2017;150:30\u20132.","journal-title":"Thromb Res"},{"issue":"11","key":"15248_CR32","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction Score. J Thromb Haemost. 2010;8(11):2450\u20137.","journal-title":"J Thromb Haemost"},{"key":"15248_CR33","doi-asserted-by":"crossref","unstructured":"Riondino S, Ferroni P, Zanzotto FM et al. Predicting VTE in cancer patients: candidate biomarkers and risk assessment Models. Cancers (Basel). 2019;11(1):95.","DOI":"10.3390\/cancers11010095"},{"issue":"11","key":"15248_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11936-019-0764-x","volume":"21","author":"KM Sanfilippo","year":"2019","unstructured":"Sanfilippo KM, Wang TF. Prevention and treatment of Cancer-Associated venous thromboembolism: a Review. Curr Treat Options Cardiovasc Med. 2019;21(11):70.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"24","key":"15248_CR35","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116(24):5377\u201382.","journal-title":"Blood"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15248-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15248-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15248-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:58:18Z","timestamp":1767020298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15248-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15248"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15248-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Third People\u2019s Hospital of Chengdu (No. [2023]S-186), and written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1888"}}